XML 40 R27.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 3,242 | $ 3,006 | $ 9,805 | $ 8,973
United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 2,381 | 2,182 | 7,080 | 6,546
International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 861 | 824 | 2,725 | 2,427
Orthopaedics |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,171 | 1,132 | 3,615 | 3,408
Orthopaedics | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 798 | 769 | 2,433 | 2,322
Orthopaedics | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 373 | 363 | 1,182 | 1,086
Orthopaedics | Knees |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 395 | 369 | 1,236 | 1,149
Orthopaedics | Knees | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 291 | 270 | 896 | 838
Orthopaedics | Knees | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 104 | 99 | 340 | 311
Orthopaedics | Hips |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 316 | 313 | 983 | 955
Orthopaedics | Hips | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 198 | 194 | 610 | 601
Orthopaedics | Hips | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 118 | 119 | 373 | 354
Orthopaedics | Trauma and Extremities |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 376 | 367 | 1,152 | 1,070
Orthopaedics | Trauma and Extremities | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 242 | 237 | 729 | 693
Orthopaedics | Trauma and Extremities | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 134 | 130 | 423 | 377
Orthopaedics | Other |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 84 | 83 | 244 | 234
Orthopaedics | Other | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 67 | 68 | 198 | 190
Orthopaedics | Other | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 17 | 15 | 46 | 44
MedSurg |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,443 | 1,336 | 4,325 | 3,977
MedSurg | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,157 | 1,052 | 3,403 | 3,143
MedSurg | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 286 | 284 | 922 | 834
MedSurg | Instruments |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 442 | 404 | 1,292 | 1,190
MedSurg | Instruments | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 352 | 316 | 1,007 | 927
MedSurg | Instruments | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 90 | 88 | 285 | 263
MedSurg | Endoscopy |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 443 | 404 | 1,335 | 1,183
MedSurg | Endoscopy | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 346 | 316 | 1,049 | 927
MedSurg | Endoscopy | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 97 | 88 | 286 | 256
MedSurg | Medical |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 492 | 464 | 1,508 | 1,413
MedSurg | Medical | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 393 | 357 | 1,158 | 1,099
MedSurg | Medical | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 99 | 108 | 350 | 314
MedSurg | Sustainability |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 66 | 64 | 190 | 191
MedSurg | Sustainability | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 66 | 63 | 189 | 190
MedSurg | Sustainability | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 0 | 0 | 1 | 1
Neurotechnology and Spine |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 628 | 538 | 1,865 | 1,588
Neurotechnology and Spine | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 426 | 361 | 1,244 | 1,081
Neurotechnology and Spine | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 202 | 177 | 621 | 507
Neurotechnology and Spine | Neurotechnology |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 435 | 353 | 1,282 | 1,036
Neurotechnology and Spine | Neurotechnology | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 284 | 222 | 820 | 660
Neurotechnology and Spine | Neurotechnology | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 150 | 131 | 462 | 376
Neurotechnology and Spine | Spine |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 193 | 185 | 583 | 552
Neurotechnology and Spine | Spine | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 142 | 139 | 424 | 421
Neurotechnology and Spine | Spine | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 52 | $ 46 | $ 159 | $ 131

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_KneesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_HipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_OtherOrthopaedicsDomain
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_MedsurgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_InstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_EndoscopyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_MedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_SustainabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_NeurotechnologyAndSpineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_NeurotechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_SpineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |